# A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

> **NCT00174473** · PHASE1,PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 49 (actual)

## Conditions studied

- Neutropenia

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT00174473
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2011-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174473, "A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00174473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*